Literature DB >> 11289038

Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers.

N Moller1, R A Rizza, G C Ford, K S Nair.   

Abstract

The contribution of the kidneys to postabsorptive endogenous glucose production is a matter of controversy. To assess whether this could relate to the use of various isotopical methods with different analytical performance capabilities, we measured glucose kinetics in 12 healthy subjects. Blood samples were taken from the femoral artery and the renal vein after 4 h of [6,6-2H2]glucose infusion (for gas chromatography [GC]/mass spectrometry [MS] analysis), and renal plasma flow was determined with paraaminohippurate. In addition, six subjects received uniformly labeled [13C]glucose (for GC/combustion/isotope ratio MS [IRMS]) and [3-3H]glucose (for counting of radioactive disintegrations). Arterial glucose concentrations (means +/- SD) were 4.2+/-0.1 mmol/l, and endogenous glucose production rates using [2H2]glucose were 2.2+/-0.1 mg x kg(-1) x min(-1) or 818+/-50 micromol/min. Dilution of [2H2]glucose across the kidney was 0.79+/-1.32%, and renal glucose production (RGP) rates were 27+/-72 micromol/min. In the six subjects receiving additional tracers, dilutions across the kidney were 2.83+/-0.72 and 0.54+/-1.20 (for [U-13C]glucose and [3-3H]glucose, respectively, the dilution with [U-13C] being higher than that with [2H2] (P = 0.007). Corresponding RGP values were 144+/-39 and 43+/-76 micromol/min for [U-13C] and [3-3H], respectively. In conclusion, we found that the highly sensitive [U-13C] GC/Combustion/IRMS technique showed consistent dilution of label across the kidney, whereas the less sensitive techniques gave some negative values and smaller RGP rates. Thus, depending on which technique is being used, a fivefold difference in calculated RGP values may be encountered. The methodological variability of our data suggests that extrapolation from regional renal measurements to the whole-body level should be perfumed with caution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289038     DOI: 10.2337/diabetes.50.4.747

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Severe hypoglycemia in a nondiabetic patient leading to acute respiratory failure.

Authors:  Muhammad Ahsan Baig; Shaukat Ali; Javeria Rasheed; Michael Bergman; Vladimir Privman
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

2.  Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.

Authors:  Simon J Fisher; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

3.  Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: effects of acute insulin withdrawal.

Authors:  N Moller; M D Jensen; R A Rizza; J C Andrews; K S Nair
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

4.  The Effect of Glucagon on Protein Catabolism During Insulin Deficiency: Exchange of Amino Acids Across Skeletal Muscle and the Splanchnic Bed.

Authors:  Haleigh James; Wilson I Gonsalves; Shankarappa Manjunatha; Surendra Dasari; Ian R Lanza; Katherine A Klaus; Adrian Vella; James C Andrews; K Sreekumaran Nair
Journal:  Diabetes       Date:  2022-08-01       Impact factor: 9.337

Review 5.  Role of the kidney in hyperglycemia in type 2 diabetes.

Authors:  Christian Meyer; John E Gerich
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 6.  Fat-induced liver insulin resistance.

Authors:  Pankaj Shah; Ananda Basu; Robert Rizza
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

7.  Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Reetta L Catlin; Robert Chan; Yuka Fujimoto; Noriyasu Sasaki; Richard L Printz; Christopher B Newgard; Masakazu Shiota
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.